DOCGO INC (DCGO) Stock Fundamental Analysis
USA - NASDAQ:DCGO - US2560861096 - Common Stock
1.09 USD
+0.04 (+3.81%)
1.1 USD
+0.01 (+0.92%)
Overall DCGO gets a fundamental rating of 3 out of 10. We evaluated DCGO against 101 industry peers in the Health Care Providers & Services industry. DCGO has a great financial health rating, but its profitability evaluates not so good. DCGO does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year DCGO has reported negative net income.
In the past year DCGO had a positive cash flow from operations.
Of the past 5 years DCGO 4 years were profitable.
In multiple years DCGO reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -4.49%, DCGO is doing worse than 66.34% of the companies in the same industry.
DCGO's Return On Equity of -6.16% is in line compared to the rest of the industry. DCGO outperforms 45.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.49% | ||
| ROE | -6.16% | ||
| ROIC | N/A |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of DCGO has declined.
DCGO's Operating Margin has declined in the last couple of years.
DCGO's Gross Margin of 33.65% is fine compared to the rest of the industry. DCGO outperforms 63.37% of its industry peers.
DCGO's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for DCGO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 33.65% |
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
DCGO has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, DCGO has a worse debt to assets ratio.
2.2 Solvency
DCGO has an Altman-Z score of 1.72. This is a bad value and indicates that DCGO is not financially healthy and even has some risk of bankruptcy.
DCGO's Altman-Z score of 1.72 is on the low side compared to the rest of the industry. DCGO is outperformed by 61.39% of its industry peers.
DCGO has a debt to FCF ratio of 0.58. This is a very positive value and a sign of high solvency as it would only need 0.58 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.58, DCGO belongs to the best of the industry, outperforming 91.09% of the companies in the same industry.
DCGO has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.14, DCGO is in the better half of the industry, outperforming 72.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 0.58 | ||
| Altman-Z | 1.72 |
ROIC/WACCN/A
WACC8.96%
2.3 Liquidity
DCGO has a Current Ratio of 2.36. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO has a better Current ratio (2.36) than 80.20% of its industry peers.
DCGO has a Quick Ratio of 2.36. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO has a better Quick ratio (2.36) than 81.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.36 | ||
| Quick Ratio | 2.36 |
3. Growth
3.1 Past
DCGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -137.93%.
DCGO shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.93% yearly.
Looking at the last year, DCGO shows a very negative growth in Revenue. The Revenue has decreased by -41.31% in the last year.
Measured over the past years, DCGO shows a very strong growth in Revenue. The Revenue has been growing by 24.60% on average per year.
EPS 1Y (TTM)-137.93%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-257.14%
Revenue 1Y (TTM)-41.31%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-51.25%
3.2 Future
The Earnings Per Share is expected to decrease by -39.69% on average over the next years. This is quite bad
DCGO is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -17.73% yearly.
EPS Next Y-274.18%
EPS Next 2Y-63.99%
EPS Next 3Y-39.69%
EPS Next 5YN/A
Revenue Next Year-49.13%
Revenue Next 2Y-28.84%
Revenue Next 3Y-17.73%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for DCGO. In the last year negative earnings were reported.
Also next year DCGO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, DCGO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.31 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
DCGO's earnings are expected to decrease with -39.69% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.99%
EPS Next 3Y-39.69%
5. Dividend
5.1 Amount
No dividends for DCGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1.09
+0.04 (+3.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners52.39%
Inst Owner Change0.06%
Ins Owners7.1%
Ins Owner Change0.95%
Market Cap106.61M
Revenue(TTM)435.97M
Net Income(TTM)-18325500
Analysts78.46
Price Target3.14 (188.07%)
Short Float %4.68%
Short Ratio2.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-163.06%
Min EPS beat(2)-311.74%
Max EPS beat(2)-14.37%
EPS beat(4)1
Avg EPS beat(4)-86.11%
Min EPS beat(4)-311.74%
Max EPS beat(4)0.93%
EPS beat(8)2
Avg EPS beat(8)-48.05%
EPS beat(12)3
Avg EPS beat(12)-63.61%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-4.02%
Min Revenue beat(2)-9.68%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-4.48%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)1.64%
Revenue beat(8)4
Avg Revenue beat(8)0.77%
Revenue beat(12)7
Avg Revenue beat(12)1.29%
Revenue beat(16)10
Avg Revenue beat(16)9.13%
PT rev (1m)0%
PT rev (3m)0.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-87.93%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.24 | ||
| P/FCF | 1.31 | ||
| P/OCF | 1.22 | ||
| P/B | 0.36 | ||
| P/tB | 0.48 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)0.83
FCFY76.27%
OCF(TTM)0.89
OCFY81.77%
SpS4.46
BVpS3.04
TBVpS2.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.49% | ||
| ROE | -6.16% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 33.65% | ||
| FCFM | 18.65% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score5
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 0.58 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 38.46% | ||
| Cap/Sales | 1.34% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.36 | ||
| Quick Ratio | 2.36 | ||
| Altman-Z | 1.72 |
F-Score5
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-137.93%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-257.14%
EPS Next Y-274.18%
EPS Next 2Y-63.99%
EPS Next 3Y-39.69%
EPS Next 5YN/A
Revenue 1Y (TTM)-41.31%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-51.25%
Revenue Next Year-49.13%
Revenue Next 2Y-28.84%
Revenue Next 3Y-17.73%
Revenue Next 5YN/A
EBIT growth 1Y-153.15%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-159.15%
EBIT Next 3Y-57.49%
EBIT Next 5YN/A
FCF growth 1Y457.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y734.5%
OCF growth 3YN/A
OCF growth 5YN/A
DOCGO INC / DCGO FAQ
What is the fundamental rating for DCGO stock?
ChartMill assigns a fundamental rating of 3 / 10 to DCGO.
Can you provide the valuation status for DOCGO INC?
ChartMill assigns a valuation rating of 2 / 10 to DOCGO INC (DCGO). This can be considered as Overvalued.
How profitable is DOCGO INC (DCGO) stock?
DOCGO INC (DCGO) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for DCGO stock?
The Earnings per Share (EPS) of DOCGO INC (DCGO) is expected to decline by -274.18% in the next year.